申请人:Attenni Barbara
公开号:US20100152128A1
公开(公告)日:2010-06-17
A compound of formula (I) and pharmaceutically acceptable salts thereof; compositions containing it and its use in medicine, particularly for the treatment or inhibition of HCV infections, and processes for making it are disclosed.
公式(I)的化合物及其药用盐;含有该化合物的组合物及其在医学上的用途,特别是用于治疗或抑制HCV感染,以及制备该化合物的方法。